Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Zoledronic acid significantly enhances radiation‑induced apoptosis against human fibrosarcoma cells by inhibiting radioadaptive signaling.

Koto K, Murata H, Kimura S, Sawai Y, Horie N, Matsui T, Ryu K, Ashihara E, Maekawa T, Kubo T, Fushiki S.

Int J Oncol. 2013 Feb;42(2):525-34. doi: 10.3892/ijo.2012.1735. Epub 2012 Dec 12.

PMID:
23242142
2.

Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents.

Koto K, Murata H, Kimura S, Horie N, Matsui T, Nishigaki Y, Ryu K, Sakabe T, Itoi M, Ashihara E, Maekawa T, Fushiki S, Kubo T.

Oncol Rep. 2010 Jul;24(1):233-9.

PMID:
20514467
3.

Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.

Tamura T, Shomori K, Nakabayashi M, Fujii N, Ryoke K, Ito H.

Oncol Rep. 2011 Apr;25(4):1139-43. doi: 10.3892/or.2011.1152. Epub 2011 Jan 18.

PMID:
21249320
5.

Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.

Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.

Lung Cancer. 2008 Feb;59(2):180-91. Epub 2007 Sep 27.

PMID:
17900752
6.

Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer.

Hashimoto K, Masumori N, Tanaka T, Maeda T, Kobayashi K, Kitamura H, Hirata K, Tsukamoto T.

Prostate. 2013 Apr;73(5):500-11. doi: 10.1002/pros.22590. Epub 2012 Sep 19.

PMID:
22996996
7.

The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis.

Sewing L, Steinberg F, Schmidt H, Göke R.

Apoptosis. 2008 Jun;13(6):782-9. doi: 10.1007/s10495-008-0211-z.

PMID:
18437576
8.

Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1.

Kijima T, Koga F, Fujii Y, Yoshida S, Tatokoro M, Kihara K.

PLoS One. 2013 May 31;8(5):e64615. doi: 10.1371/journal.pone.0064615. Print 2013.

9.

Combined effects of bisphosphonate and radiation on osteosarcoma cells.

Ryu K, Murata H, Koto K, Horie N, Matsui T, Nishigaki Y, Sakabe T, Takeshita H, Itoi M, Kimura S, Ashihara E, Maekawa T, Fushiki S, Kubo T.

Anticancer Res. 2010 Jul;30(7):2713-20.

PMID:
20683003
10.

The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro.

Mitrofan LM, Pelkonen J, Mönkkönen J.

Bone. 2009 Dec;45(6):1153-60. doi: 10.1016/j.bone.2009.08.010. Epub 2009 Aug 21.

PMID:
19699819
12.

Anticancer effects of zoledronic acid against human osteosarcoma cells.

Kubista B, Trieb K, Sevelda F, Toma C, Arrich F, Heffeter P, Elbling L, Sutterlüty H, Scotlandi K, Kotz R, Micksche M, Berger W.

J Orthop Res. 2006 Jun;24(6):1145-52.

13.

p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acid.

Kuroda J, Kimura S, Segawa H, Sato K, Matsumoto S, Nogawa M, Yuasa T, Kobayashi Y, Yoshikawa T, Ottmann OG, Maekawa T.

Cancer Sci. 2004 Feb;95(2):186-92.

14.

Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.

Ottewell PD, Mönkkönen H, Jones M, Lefley DV, Coleman RE, Holen I.

J Natl Cancer Inst. 2008 Aug 20;100(16):1167-78. doi: 10.1093/jnci/djn240. Epub 2008 Aug 11.

PMID:
18695136
15.

Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis.

Evdokiou A, Labrinidis A, Bouralexis S, Hay S, Findlay DM.

Bone. 2003 Aug;33(2):216-28.

PMID:
14499355
16.

Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions.

Okamoto S, Jiang Y, Kawamura K, Shingyoji M, Tada Y, Sekine I, Takiguchi Y, Tatsumi K, Kobayashi H, Shimada H, Hiroshima K, Tagawa M.

Cell Death Dis. 2014 Nov 13;5:e1517. doi: 10.1038/cddis.2014.475.

17.

The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide.

Ural AU, Yilmaz MI, Avcu F, Pekel A, Zerman M, Nevruz O, Sengul A, Yalcin A.

Int J Hematol. 2003 Dec;78(5):443-9.

PMID:
14704038
19.

Zoledronic acid induces cell-cycle prolongation in murine lung cancer cells by perturbing cyclin and Ras expression.

Li YY, Chang JW, Liu YC, Wang CH, Chang HJ, Tsai MC, Su SP, Yeh KY.

Anticancer Drugs. 2011 Jan;22(1):89-98. doi: 10.1097/CAD.0b013e3283400a05.

PMID:
20926944
20.

Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.

Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I.

Mol Cancer Ther. 2009 Oct;8(10):2821-32. doi: 10.1158/1535-7163.MCT-09-0462. Epub 2009 Sep 29.

Supplemental Content

Support Center